Retinal neurons curb inflammation and enhance revascularization in ischemic retinopathies via proteinase-activated receptor-2

American Journal of Pathology

Volumn 185, Issue 2, 2015, Pages 581-595

  Sitaras, Nicholas ^a,b   Rivera, José Carlos ^a,b   Noueihed, Baraa ^c   Bien Aimé, Milsa ^b   Zaniolo, Karine ^d   Omri, Samy ^a,b   Hamel, David ^a   Zhu, Tang ^a   Hardy, Pierre ^a   Sapieha, Przemyslaw ^b   Joyal, Jean Sébastien ^a,c   Chemtob, Sylvain ^a,b,c  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; PEPTIDE DERIVATIVE; PROTEINASE ACTIVATED RECEPTOR 2; SEMAPHORIN 3A; SHORT HAIRPIN RNA; STRESS ACTIVATED PROTEIN KINASE; EYE PROTEIN; IL1B PROTEIN, MOUSE; OLIGOPEPTIDE; PROTEASE-ACTIVATED RECEPTOR 3; SEMA3A PROTEIN, MOUSE; SERYL-LEUCYL-ISOLEUCYL-GLYCYL-ARGINYL-LEUCINE; THROMBIN RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KNOCKOUT MOUSE; LENTIVIRINAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; RETINA GANGLION CELL; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; RETINA NERVE CELL; UPREGULATION; AGONISTS; ANIMAL; GENETICS; ISCHEMIA; METABOLISM; PATHOLOGY; RETINAL DISEASES;

ANIMALS; EYE PROTEINS; INFLAMMATION; INTERLEUKIN-1BETA; ISCHEMIA; MICE; MICE, KNOCKOUT; OLIGOPEPTIDES; RECEPTORS, THROMBIN; RETINAL DISEASES; RETINAL NEURONS; SEMAPHORIN-3A;

EID: 84922321981     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.10.020     Document Type: Article

References (59)

1. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al; The Meta-Analysis for Eye Disease (Meta-eye) Study Group: Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012, 35:556-564
2. Gilbert C, Rahi J, Eckstein M, O'Sullivan J, Foster A: Retinopathy of prematurity in middle-income countries. Lancet 1997, 350:12-14
3. Sapieha P, Hamel D, Shao Z, Rivera JC, Zaniolo K, Joyal JS, Chemtob S: Proliferative retinopathies: angiogenesis that blinds. Int J Biochem Cell Biol 2010, 42:5-12
4. Fulton A, Hansen R, Moskowitz A, Akula J: The neurovascular retina in retinopathy of prematurity. Prog Retin Eye Res 2009, 28: 452-482
5. Demircan N, Safran BG, Soylu M, Ozcan AA, Sizmaz S: Determination of vitreous interleukin-1 (il-1) and tumour necrosis factor (tnf) levels in proliferative diabetic retinopathy. Eye (Lond) 2006, 20: 1366-1369
6. Mocan MC, Kadayifcilar S, Eldem B: Elevated intravitreal interleukin-6 levels in patients with proliferative diabetic retinopathy. Can J Ophthalmol 2011, 41:747-752
7. Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, Levison SW: Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy. Diabetes 2005, 54:1559-1565
8. Rivera JC, Sitaras N, Noueihed B, Hamel D, Madaan A, Zhou T, Honore J, Quiniou C, Joyal J, Hardy P, Sennlaub F, Lubell W, Chemtob S: Microglia and IL-1β in ischemic retinopathy elicit microvascular degeneration through neuronal Semaphorin3A. Arterioscler Thromb Vasc Biol 2013, 133:1881-1891
9. dell'Omo R, Semeraro F, Bamonte G, Cifariello F, Romano MR, Costagliola C: Vitreous mediators in retinal hypoxic diseases. Mediators Inflamm 2013:1-16
10. Ishida S, Yamashiro K, Usui T, Kaji Y, Ogura Y, Hia T, Honda Y, Oguchi Y, Adamis A: Leukocytes mediate retinal vascular remodeling during dvelopment and vaso-obliteration in disease. Nat Med 2003, 9:781-789
11. Joyal JS, Sitaras N, Binet F, Rivera JC, Stahl A, Zaniolo K, Shao Z, Polosa A, Zhu T, Hamel D, Djavari M, Kunik D, Honoré JC, Picard E, Zabeida A, Varma DR, Hickson G, Mancini J, Klagsbrun M, Costantino S, Beauséjour C, Lachapelle P, Smith LE, Chemtob S, Sapieha P: Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A. Blood 2011, 117: 6024-6035
12. Dorfman A, Dembinska O, Chemtob S, Lachapelle P: Early manifestations of postnatal hyperoxia on the retinal structure and function of the neonatal rat. Invest Ophthalmol Vis Sci 2008, 49:458-466
13. Teshima S, Nakanishi H, Nishizawa M, Kitagawa K, Kaibori M, Yamada M, Habara K, Kwon A, Kamiyama Y, Ito S, Okumura T: Up-regulation of IL-1 receptor through PI3K/Akt is essential for the induction of iNOS gene expression in hepatocytes. J Hepatol 2004, 40:616-623
14. Skundric DS, Bealmear B, Lisak RP: Induced upregulation of IL-1, IL-1RA and IL-1R type I gene expression by Schwann cells. J Neuroimmunol 1997, 74:9-18
15. Kowluru R, Zhong Q, Santos J: Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9. Expert Opin Investig Drugs 2012, 21:797-805
16. Soh UJK, Dores MR, Chen B, Trejo J: Signal transduction by protease-activated receptors. Br J Pharmacol 2010, 160:191-203
17. Uusitalo-Jarvinen H, Kurokawa T, Mueller BM, Andrade-Gordon P, Friedlander M, Ruf W: Role of protease activated receptor 1 and 2 signaling in hypoxia-induced angiogenesis. Arterioscler Thromb Vasc Biol 2007, 27:1456-1462
18. Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, Dorfleutner A, Carmeliet P, Mueller BM, Friedlander M, Ruf W: Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 2004, 10:502-509
19. Tsai SH, Sheu MT, Liang YC, Cheng HT, Fang SS, Chen C: TGF-β inhibits IL-1β-activated PAR-2 expression through multiple pathways in human primary synovial cells. J Biomed Sci 2009, 16: 97-111
20. Ritchie E, Saka M, MacKenzie C, Drummond R, Wheeler-Jones C, Kanke T, Plevin R: Cytokine upregulation of proteinase-activatedreceptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase β in human endothelial cells. Br J Pharmacol 2007, 150:1044-1054
21. Boileau C, Amiable N, Martel-Pelletier J, Fahmi H, Duval N, Pelletier J: Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study. Arthritis Res Ther 2007, 9:R121
22. Noorbakhsh F, Vergnolle N, McArthur JC, Silva C, Andrade-Gordon P, Vodjgani M, Hollenberg M, Power C: Protease-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. J Immunol 2005, 174:7320-7329
23. Suharti C, van Gorp EC, Setiati TE, Dolmans WM, Djokomoeljanto RJ, Hack CE, Hugo ten C, van der Meer JW: The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome. Thromb Haemost 2002, 87:42-46
24. Smith LE, Wesoloiuski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994, 35:101-111
25. Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM, Seaward MR, Willett KL, Aderman CM, Guerin KI, Hua J, Lofqvist C, Hellstrom A, Smith LE: The mouse retina as an angiogenesis model. Invest Ophthalmol Vis Sci 2010, 51: 2813-2826
26. Stahl A, Connor KM, Sapieha P, Willett KL, Krah NM, Dennison RJ, Chen J, Guerin KI, Smith LE: Computer-aided quantification of retinal neovascularization. Angiogenesis 2009, 12:297-301
27. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L: A third-generation lentivirus vector with a conditional packaging system. J Virol 1998, 72:8463
28. Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, Cho JH, Honoré JC, Kermorvant-Duchemin E, Varma DR, Tremblay S, Leduc M, Rihakova L, Hardy P, Klein WH, Mu X, Mamer O, Lachapelle P, Di Polo A, Beauséjour C, Andelfinger G, Mitchell G, Sennlaub F, Chemtob S: The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med 2008, 14: 1067-1076
29. Chang-Ling T, Neill AL, Hunt NH: Early microvascular changes in murine cerebral malaria detected in retinal wholemounts. Am J Pathol 1992, 140:1121-1130
30. Barbaric I, Miller G, Dear T: Appearances can be deceiving: phenotypes of knockout mice. Brief Funct Genomic Proteomic 2007, 6: 91-103
31. Schmidlin F, Amadesi S, Dabbagh K, Lewis DE, Knott P, Bunnet NW, Gater PR, Geppetti P, Bertrand C, Stevens ME: Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 2002, 169:5315-5321
32. Binet F, Mawambo G, Sitaras N, Tetreault N, Lapalme E, Favret S, Cerani A, Leboeuf D, Tremblay S, Rezende F, Juan A, Stahl A, Joyal J, Milot É, Kaufman R, Guimond M, Kennedy T, Sapieha P: Neuronal ER stress impedes myeloid-cell-induced vascular regeneration through ire1-alpha degradation of netrin-1. Cell Metab 2013, 17:353-371
33. Cerani A, Tetreault N, Menard C, Lapalme E, Patel C, Sitaras N, Beaudoin F, Leboeuf D, De Guire V, Binet F, Dejda A, Rezende F, Miloudi K, Sapieha P: Neuron-derived Semaphorin 3A is an early inducer of vascular permeability in diabetic retinopathy via neuropilin-1. Cell Metab 2013, 18:505-518
34. Kaufmann R, Hollenberg M: Proteinase-activated receptors (PARs) and calcium signaling in cancer. Adv Exp Med Biol 2012, 740:979-1000
35. Kim Y, West XZ, Byzova TV: Inflammation and oxidative stress in angiogenesis and vascular disease. J Mol Med 2013, 91:323-328
36. Gardiner TA, Gibson DS, de Gooyer TE, de la Cruz VF, McDonald DM, Stitt A: Inhibition of tumor necrosis factor-α improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am J Pathol 2005, 166: 637-644
37. Meyer N, Christoph J, Makrinioti H, Indermitte P, Rhyner C, Soyka M, Eiwegger T, Chalubinski T, Wanke K, Fujita H, Wawrzyniak P, Burgler S, Zhang S, Akdis M, Menz G, Akdis C: Inhibition of angiogenesis by IL-32: possible role in asthma. J Allergy Clin Immunol 2012, 129:964-973.e7
38. Massague J, Blain S, Lo R: TGF-beta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103:295-309
39. Kermorvant-Duchemin E, Sennlaub F, Sirinyan M, Brault S, Andelfinger G, Kooli A, Germain S, Ong H, d'Orleans-Juste P, Gobeil F, Zhu T, Boisvert C, Hardy P, Jain K, Falck JR, Balazy M, Chemtob S: Trans-arachidonic acids generated during nitrative stress induce a thrombospondin-1-dependent microvascular degeneration. Nat Med 2005, 11:1339-1345
40. Minuzzo S, Moserle L, Indraccolo S, Amadori A: Angiogenesis meets immunology: cytokine gene therapy of cancer. Mol Aspects Med 2007, 28
41. Shen H, Yao P, Lee E, Greenhalgh D, Soulika A: Interferon-gamma inhibits healing post scald burn injury. Wound Repair Regen 2012, 20:580-591
42. Rothmeier A, Ruf W: Protease-activated receptor 2 signaling in inflammation. Semin Immunopathol 2012, 34:133-149
43. Ossovskaya VS, Nunnet N: Protease-activated receptors: contribution to physiology and disease. Physiol Rev 2004, 84:579-621
44. Paumelle R, Tulasne D, Leroy C, Coll J, Vandenbunder B, Fafeur V: Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in Madin-Darby canine kidney epithelial cells. Mol Biol Cell 2000, 11:3751-3763
45. Tremblay S, Miloudi K, Chaychi S, Favret S, Binet F, Polosa A, Lachapelle P, Chemtob S, Sapieha P: Systemic inflammation perturbs developmental retinal angiogenesis and neuroretinal function. Invest Ophthalmol Vis Sci 2013, 54:8125-8139
46. Lange C, Ehlken C, Stahl A, Martin G, Hansen L, Agostini H: Kinetics of retinal vaso-obliteration and neovascularisation in the oxygen-induced retinopathy (OIR) mouse model. Graefes Arch Clin Exp Ophthalmol 2009, 247:1205-1211
47. Bucci M, Roviezzo F, Cirino G: Protease-activated receptor-2 (PAR2) in cardiovascular system. Vascul Pharmacol 2005, 43: 247-253
48. Ramachandran R, Hollenberg MD: Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol 2008, 153:S263-S282
49. Luo W, Wang Y, Reiser G: Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection. Brain Res Rev 2007, 56:331-345
50. Ramachandran R, Noorbakhsh F, DeFea K, Hollenberg MD: Targeting proteinase-activated receptors: therapeutic potential and challenges. Nat Rev Drug Discov 2012, 11:69-86
51. Afkhami-Goli A, Noorbakhsh F, Keller AJ, Vergnolle N, Westaway D, Jhamandas JH, Andrade-Gordon P, Hollenberg MD, Arab H, Dyck RH, Power C: Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease. J Immunol 2007, 179:5493-5503
52. Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, Warren KG, Andrade-Gordon P, Hollenberg MD, Power C: Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 2006, 203:425-435
53. Jin G, Hayashi T, Kawagoe J, Takizawa T, Nagata T, Nagano I, Syoj I M, Abe K: Deficiency of PAR-2 gene increases acute focal ischemic brain injury. J Cereb Blood Flow Metab 2005, 25: 302-313
54. Wang H, Ubl J, Reiser G: Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 2002, 37:53-63
55. Hellström A, Smith LE, Dammann O: Retinopathy of prematurity. Lancet 2013, 382:1445-1457
56. Miller J, Couter JL, Strauss E, Ferrara N: Vascular endothelial growth factor A in intraocular vascular disease. Ophthalmology 2012, 120:106-114
57. Wang S, Park J, Duh E: Novel targets against retinal angiogenesis in diabetic retinopathy. Curr Diab Rep 2012, 12:355-363
58. Hernandez C, Simo R: Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice. Expert Opin Investig Drugs 2007, 16:1209-1226
59. Stewart MW: The expanding role of vascular endothelial growth factor inhibitors in ophthalmology. Mayo Clin Proc 2012, 87:77-88